首页|期刊导航|纳微快报（英文）|From Bench to the Clinic: The Path to Translation of Nanotechnology?Enabled mRNA SARS?CoV?2 Vaccines

From Bench to the Clinic: The Path to Translation of Nanotechnology?Enabled mRNA SARS?CoV?2 Vaccines

Diana O.Lopez?Cantu Xichi Wang Hector Carrasco?Magallanes Samson Afewerki Xingcai Zhang Joseph V.Bonventre Guillermo U.Ruiz?Esparza

纳微快报（英文）2022，Vol.14Issue(3)：1-31,31.

From Bench to the Clinic: The Path to Translation of Nanotechnology?Enabled mRNA SARS?CoV?2 Vaccines

Diana O.Lopez?Cantu ¹Xichi Wang ²Hector Carrasco?Magallanes ³Samson Afewerki ⁴Xingcai Zhang ¹Joseph V.Bonventre ²Guillermo U.Ruiz?Esparza³

作者信息

1. Division of Engineering in Medicine,Department of Medicine,Brigham and Women's Hospital,Harvard Medical School,Boston,MA 02115,USA
2. Division of Health Sciences and Technology,Harvard University-Massachusetts Institute of Technology,Boston,MA 02115,USA
3. Division of Renal Medicine,Department of Medicine,Brigham and Women's Hospital,Harvard Medical School,Boston,MA 02115,USA
4. Tecnologico de Monterrey,School of Engineering and Sciences,64849 Monterrey,NL,Mexico
折叠

摘要

关键词

Nanovaccines/mRNA/Coronavirus/SARS-CoV-2/COVID-19

Key words

Nanovaccines/mRNA/Coronavirus/SARS-CoV-2/COVID-19

引用本文复制引用

Diana O.Lopez?Cantu,Xichi Wang,Hector Carrasco?Magallanes,Samson Afewerki,Xingcai Zhang,Joseph V.Bonventre,Guillermo U.Ruiz?Esparza..From Bench to the Clinic: The Path to Translation of Nanotechnology?Enabled mRNA SARS?CoV?2 Vaccines[J].纳微快报（英文）,2022,14(3):1-31,31.

基金项目

The authors acknowledge the financial and scientific support of Brigham and Women's Hospital,Harvard Medical School and Massachusetts Institute of Technology.JVB is supported by NIH Grants R01DK072381,R37DK039773,and TR-002155. （）

纳微快报（英文）

OACSCDCSTPCDEISCI

ISSN：2311-6706

访问量0

下载量0

段落导航